Travelers Indemnity Co. has asked a federal judge not to dismiss its $47 million lawsuit filed against Pfizer Inc., contending that the claim is not time-barred. The suit involves the epilep... Read more
On April 3, 2013, the First Circuit Court of Appeals ruled that drug manufacturer Pfizer, Inc.’s fraudulent marketing of the drug Neurontin directly caused plaintiffs Kaiser Foundation Healt... Read more
Some antiseizure drugs used to treat epilepsy as well as depression, chronic pain, migraine, bipolar disorder, and other conditions are said to be associated with a higher risk of suicide an... Read more
A Boston jury has found that Pfizer, Inc. violated the federal racketeering law by improperly promoting its epilepsy drug Neurontin. The world’s largest drug maker was ordered by the j... Read more
Neurontin, manufactured by Pfizer subsidiary Parke-Davis, is a medication originally developed for the treatment of epilepsy. It was approved by the FDA in 1994, and in 2002 an indication wa... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.